Combined Neoadjuvant-Adjuvant Immunotherapy and Abdominoperineal Resection for a Primary Anorectal Melanoma: A Case Report
2024

Case Report on Anorectal Melanoma Treatment

Sample size: 1 publication Evidence: low

Author Information

Author(s): Muacevic Alexander, Adler John R, Papanikolaou Georgios E, Tsimogiannis Konstantinos, Kampletsas Eleftherios, Chatzoglou Theocharis, Varvarousis Dimitrios N

Primary Institution: Metropolitan General Hospital, Athens, GRC

Hypothesis

Can a combination of immunotherapy and surgery improve outcomes for patients with anorectal melanoma?

Conclusion

The patient is disease-free five years after treatment with immunotherapy and surgery, indicating a promising approach for anorectal melanoma.

Supporting Evidence

  • Anorectal melanoma is rare and often misdiagnosed.
  • The patient was disease-free at a five-year follow-up after treatment.
  • Immunotherapy combined with surgery may improve outcomes for anorectal melanoma.

Takeaway

A 73-year-old woman with a rare type of cancer was treated with medicine and surgery, and now she is healthy after five years.

Methodology

The patient received neoadjuvant immunotherapy followed by surgery, with ongoing immunotherapy for five years.

Limitations

The study is based on a single case report, limiting generalizability.

Participant Demographics

73-year-old Caucasian female with a history of type 2 diabetes and other health issues.

Digital Object Identifier (DOI)

10.7759/cureus.73931

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication